Aptevo Therapeutics Inc.
APVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671584
No open-market purchases or sales by Aptevo Therapeutics Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $224.3K in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Aptevo Therapeutics Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 27 | 27 | 0 |
| Shares | 867.6K | 963.4K | +95.8K (+11.0%) |
| Value | $2.63M | $2.27M | −$363.5K (−13.8%) |
New holders (5)
Institutions that held Aptevo Therapeutics Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of Montreal | 10,000 | $61.4K | 0.00% |
| Two Sigma Securities, LLC | 14,877 | $34.5K | 0.00% |
| Dimensional Fund Advisors LP | 12,705 | $29.0K | 0.00% |
| Money Concepts Capital Corp | 7 | $16 | 0.00% |
| FMR LLC | 3 | $8 | 0.00% |
Sold out (5)
Institutions that held Aptevo Therapeutics Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Virtu Financial LLC | 28,421 | $86.0K |
| Royal Bank of Canada | 714 | $2.00K |
| US Bancorp | 1 | $0 |
| Harbour Investments, Inc. | 125 | $0 |
| Advisor Group Holdings, Inc. | 30 | $0 |